56 related articles for article (PubMed ID: 24729354)
1. Molecular Pathogenesis of Multiple Myeloma: Clinical Implications.
Maura F; Bergsagel PL
Hematol Oncol Clin North Am; 2024 Apr; 38(2):267-279. PubMed ID: 38199896
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
Dispenzieri A; Katzmann JA; Kyle RA; Larson DR; Melton LJ; Colby CL; Therneau TM; Clark R; Kumar SK; Bradwell A; Fonseca R; Jelinek DF; Rajkumar SV
Lancet; 2010 May; 375(9727):1721-8. PubMed ID: 20472173
[TBL] [Abstract][Full Text] [Related]
3. Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma.
Greenberg AJ; Cousin M; Kumar S; Ketterling RP; Knudson RA; Larson D; Colby C; Scott C; Vachon CM; Vincent Rajkumar S
Eur J Haematol; 2013 Sep; 91(3):193-195. PubMed ID: 23647020
[TBL] [Abstract][Full Text] [Related]
4. Distinct and shared three-dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma.
Sathitruangsak C; Righolt CH; Klewes L; Tung Chang D; Kotb R; Mai S
Int J Cancer; 2017 Jan; 140(2):400-410. PubMed ID: 27711972
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival.
Chi J; Ballabio E; Chen XH; Kušec R; Taylor S; Hay D; Tramonti D; Saunders NJ; Littlewood T; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS; Lawrie CH
Biol Direct; 2011 May; 6():23. PubMed ID: 21592325
[TBL] [Abstract][Full Text] [Related]
6. Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma.
Barwick BG; Gupta VA; Vertino PM; Boise LH
Front Immunol; 2019; 10():1121. PubMed ID: 31231360
[TBL] [Abstract][Full Text] [Related]
7. Superior detection rate of plasma cell FISH using FACS-FISH.
Gagnon MF; Midthun SM; Fangel JA; Schuh CM; Luoma IM; Pearce KE; Meyer RG; Ailawadhi S; Arribas MJ; Braggio E; Fonseca R; Rajkumar SV; Zepeda-Mendoza C; Xu X; Greipp PT; Timm MM; Otteson GE; Shi M; Jevremovic D; Olteanu H; Peterson JF; Ketterling RP; Kumar S; Baughn LB
Am J Clin Pathol; 2024 Jan; 161(1):60-70. PubMed ID: 37658775
[TBL] [Abstract][Full Text] [Related]
8. Myeloma genetics and genomics: practice implications and future directions.
Faiman B
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):436-40. PubMed ID: 25127058
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach.
Khalili P; Maddah R; Maleknia M; Shateri Amiri B; Forouzani F; Hasanvand A; Rezaeeyan H
Mol Biotechnol; 2023 Aug; 65(8):1275-1286. PubMed ID: 36504354
[TBL] [Abstract][Full Text] [Related]
10. FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis.
Fromme JE; Schmitz K; Wachter A; Grzelinski M; Zielinski D; Koppel C; Conradi LC; Homayounfar K; Hugo T; Hugo S; Lukat L; Rüschoff J; Ströbel P; Ghadimi M; Beißbarth T; Reuter-Jessen K; Bleckmann A; Schildhaus HU
Oncotarget; 2018 Aug; 9(63):32204-32218. PubMed ID: 30181810
[TBL] [Abstract][Full Text] [Related]
11. Expressed fusion gene landscape and its impact in multiple myeloma.
Cleynen A; Szalat R; Kemal Samur M; Robiou du Pont S; Buisson L; Boyle E; Chretien ML; Anderson K; Minvielle S; Moreau P; Attal M; Parmigiani G; Corre J; Munshi N; Avet-Loiseau H
Nat Commun; 2017 Dec; 8(1):1893. PubMed ID: 29196615
[TBL] [Abstract][Full Text] [Related]
12. MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy.
Holien T; Misund K; Olsen OE; Baranowska KA; Buene G; Børset M; Waage A; Sundan A
Oncotarget; 2015 Sep; 6(26):22698-705. PubMed ID: 26087190
[TBL] [Abstract][Full Text] [Related]
13. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
15. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing primary and secondary translocations in multiple myeloma.
Gabrea A; Leif Bergsagel P; Michael Kuehl W
DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis and a consequent classification of multiple myeloma.
Bergsagel PL; Kuehl WM
J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of immunoglobulin light chain gene aberrations as revealed by FISH in multiple myeloma and MGUS.
Türkmen S; Binder A; Gerlach A; Niehage S; Theodora Melissari M; Inandiklioglu N; Dörken B; Burmeister T
Genes Chromosomes Cancer; 2014 Aug; 53(8):650-6. PubMed ID: 24729354
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
